Effect of Monocyte-to-Lymphocyte Ratio on Heart Failure Characteristics and Hospitalizations in a Coronary Angiography Cohort.

[1]  Li Li,et al.  Monocyte/lymphocyte ratio predicts the severity of coronary artery disease: a syntax score assessment , 2017, BMC Cardiovascular Disorders.

[2]  S. Hazen,et al.  Monocyte to Lymphocyte Ratio is Associated with Adverse Long Term Outcomes in Patients with Heart Failure , 2016 .

[3]  H. D. den Ruijter,et al.  Routinely analyzed leukocyte characteristics improve prediction of mortality after coronary angiography , 2016, European journal of preventive cardiology.

[4]  M. Voskuil,et al.  Hematological Parameters Improve Prediction of Mortality and Secondary Adverse Events in Coronary Angiography Patients , 2015, Medicine.

[5]  H. Nathoe,et al.  Gender differences in health-related quality of life in patients undergoing coronary angiography , 2015, Open Heart.

[6]  Chi‐Hang Lee,et al.  Ethnicity Modifies Associations between Cardiovascular Risk Factors and Disease Severity in Parallel Dutch and Singapore Coronary Cohorts , 2015, PloS one.

[7]  M. Nahrendorf,et al.  Monocytes in Myocardial Infarction , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[8]  R. Abbott,et al.  Total and differential white blood cell counts predict eight-year incident coronary heart disease in elderly Japanese-American men: the Honolulu Heart Program. , 2015, Atherosclerosis.

[9]  S. Frantz,et al.  Role of Lymphocytes in Myocardial Injury, Healing, and Remodeling After Myocardial Infarction , 2015, Circulation research.

[10]  J. Baugh,et al.  Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target , 2014, Heart Failure Reviews.

[11]  Guangyu Zhang,et al.  Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. , 2014, Atherosclerosis.

[12]  Xia Yang,et al.  A Systems Biology Framework Identifies Molecular Underpinnings of Coronary Heart Disease , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[13]  D. Fliser,et al.  Cd14؉؉cd16؉ Monocytes Independently Predict Cardiovascular Events a Cohort Study of 951 Patients Referred for Elective Coronary Angiography , 2022 .

[14]  W. März,et al.  Which leukocyte subsets predict cardiovascular mortality? From the LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study. , 2012, Atherosclerosis.

[15]  C. Schalkwijk,et al.  Loss of DPP4 activity is related to a prothrombogenic status of endothelial cells: implications for the coronary microvasculature of myocardial infarction patients , 2011, Basic Research in Cardiology.

[16]  C. Barisione,et al.  CD14CD16 Monocyte Subset Levels in Heart Failure Patients , 2010, Disease markers.

[17]  Jing Yuan,et al.  Defective Circulating CD4+CD25+Foxp3+CD127low Regulatory T-cells in Patients with Chronic Heart Failure , 2010, Cellular Physiology and Biochemistry.

[18]  T. Nakata,et al.  Prediction of new-onset refractory congestive heart failure using gated myocardial perfusion SPECT imaging in patients with known or suspected coronary artery disease subanalysis of the J-ACCESS database. , 2009, JACC. Cardiovascular imaging.

[19]  F. Tondato,et al.  Bone marrow-derived B cells preserve ventricular function after acute myocardial infarction. , 2009, JACC. Cardiovascular interventions.

[20]  M. Kleinewietfeld,et al.  Regulatory T Cells Ameliorate Angiotensin II–Induced Cardiac Damage , 2009, Circulation.

[21]  Marc A Pfeffer,et al.  Predictors of Heart Failure in Patients With Stable Coronary Artery Disease: A PEACE Study , 2009, Circulation. Heart failure.

[22]  Gerard Pasterkamp,et al.  Targeted Deletion of Nuclear Factor &kgr;B p50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction , 2009, Circulation research.

[23]  J. J. Rivera,et al.  Markers of inflammation and coronary artery calcification: a systematic review. , 2008, Atherosclerosis.

[24]  K. Lappegård,et al.  Anti‐Inflammatory Effect of Cardiac Resynchronization Therapy , 2006, Pacing and clinical electrophysiology : PACE.

[25]  C. Brayne,et al.  Neutrophil counts, monocyte counts and cardiovascular disease in the elderly , 2004, Experimental Gerontology.

[26]  A. Matsumori,et al.  Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[27]  M. Eren,et al.  Lymphocytopenia is associated with poor NYHA functional class in chronic heart failure patients with reduced ejection fraction. , 2015, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[28]  I. Lavi,et al.  Research Article Changes in the Monocytic Subsets CD14 dim CD16 + and CD14 ++ CD16 in Chronic Systolic Heart Failure Patients , 2012 .

[29]  Jing Yuan,et al.  Regulatory T cells ameliorate cardiac remodeling after myocardial infarction , 2011, Basic Research in Cardiology.

[30]  A. Egberts,et al.  Linking laboratory and medication data: new opportunities for pharmacoepidemiological research , 2007, Clinical chemistry and laboratory medicine.

[31]  H. Miller,et al.  Pathophysiological role of cytokines in congestive heart failure. , 2001, Annual review of medicine.